A Change of Adrenomedulium and Endothlin-1 in Patients with Hypertension and Coronary Artery Lesion

孙宁玲,王伟民,李明,赵红,陈步星,王鸿懿,刘喜荣,翟莹

DOI: https://doi.org/10.3760/j:issn:0253-3758.2001.04.006

2001-01-01

Abstract:Objective To find the change of adrenomedulium(ADM) and endothelin-1(ET-1) levels after interventional treatment in patients with hypertension and coronary artery lesion, and discuss its meaning. Methods 25 patients with coronary heart disease and hypertension (group A), and 21 patients with coronary heart disease without hypertension(group B), received PTCA and stent implantation. Fifteen patients with coronary heart disease and hypertension without interventional treatment (group C) were used as conterels. Venous blood was sampled before and after interventional treatment (including instantly and 24 hours after operation) in total of 61 patients.The plasma concentrations of ADM and ET-1 were measured by RIA. Results 1.The blood pressure and heart rate didn′t change after operation in the three groups. The cardiac function of the patients with triple vessel disease was significantly lower than the others. The LVEF in group A was 43.9%/62.0%, 50%/57.5% in group B and 44.6%/60.8% in group C before and after operation respectively. 2.The plasma concentrations of endothelin-1 and ADM increased and lasted for 24 hours in patients of group A after receiving interventional treatment. The increase was more significant in those with triple vessel disease. (compared with group B and C, P<0.05). Conclusion In patients with hypertension and coronary artery lesion, the interventional treatment may stimulate the release of vasoactive peptide. Therefore, effectively controlling the blood pressure and correcting the dysfunction of the endothelium are the important therapeutic steps before and after the interventional treatment.